{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-007863","form_type":"8-K","ticker":"AGL","cik":"0001831097","company_name":"agilon health, inc.","filed_at":"2022-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.680855+00:00","generated_at":"2026-06-25T23:58:52.402909+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"agilon health Q1 revenue up 58% to $653M, net income $1M, guides FY2022 revenue $2.5-2.6B","bullets":["Revenue $653M (+58% YoY); normalized revenue growth 49%. Net income $1M vs $15M loss.","Medical margin $86M (+66% YoY), representing 13.2% of revenue (vs 12.6%).","Adjusted EBITDA $12M, up from $4M last year.","Medicare Advantage members 250,000 (+51% YoY); same geography +20%.","FY2022 guidance: revenue $2,505-2,590M, medical margin $290-305M, adjusted EBITDA $0-10M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-007863","json":"https://secwatch.observer/filing/0000950170-22-007863.json","markdown":"https://secwatch.observer/filing/0000950170-22-007863.md","text":"https://secwatch.observer/filing/0000950170-22-007863.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831097/000095017022007863/0000950170-22-007863-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831097/000095017022007863/agl-20220505.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T23:58:52.402909+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}